Enliven Therapeutics Inc (ELVN)

NASDAQ · Pharmaceuticals

59.95
+0.42 (+0.70%)
Updated Aug 18, 2:03 PM ET
AI Rating
Buy
Overall Score
64
Trend
75
Momentum
64
Risk
46

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Enliven Therapeutics Inc is trading at $59.95, up 0.70% on the session. The 50 day average sits at $50.40 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 62.9, which reads as strong, and MACD is bearish crossover. Volume is below average.

The nearest support is around $49.56 with resistance near $62.32, so that band frames the current range. Average daily movement is roughly $2.70, or about 4.5% of the share price, which is what any stop placement has to allow for. The overall health score of 64 out of 100 combines a trend score of 75, momentum of 64 and a risk score of 46.

Technical indicators

RSI (14)
62.9
strong
MACD
2.448
bearish crossover
SMA 20
56.27
SMA 50
50.40
SMA 200
--
unknown
ATR (14)
2.70
avg daily range
Support
49.56
Resistance
62.32
Volume vs 20d
0.34x
below average
Volatility
40.3%
annualised
1 month
+15.65%
3 months
+36.54%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.